Epstein-Barr Virus Infection Is Common in Inflamed Gastrointestinal Mucosa

[1]  U. Ghoshal,et al.  Epstein-Barr virus DNA load and its association with Helicobacter pylori infection in gastroduodenal diseases. , 2011, The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases.

[2]  Jaap M Middeldorp,et al.  Viral miRNAs exploiting the endosomal-exosomal pathway for intercellular cross-talk and immune evasion. , 2011, Biochimica et biophysica acta.

[3]  J. Arola,et al.  Human herpesvirus 6 and cytomegalovirus in ileocolonic mucosa in inflammatory bowel disease , 2011, Scandinavian journal of gastroenterology.

[4]  N. Raab-Traub,et al.  Microvesicles and Viral Infection , 2011, Journal of Virology.

[5]  J. Crowley,et al.  14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial , 2011, The Lancet.

[6]  R. Marciniak,et al.  Inflammatory bowel disease - is there something new in the immunological background? , 2011, Folia histochemica et cytobiologica.

[7]  E. Jaffe,et al.  Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphoma. , 2011, Blood.

[8]  A. Iwasaki,et al.  Genome–virome interactions: examining the role of common viral infections in complex disease , 2011, Nature Reviews Microbiology.

[9]  A. Krasinskas,et al.  Epstein-Barr Virus Gastritis: Rare or Rarely Sampled? A Case Report , 2011, International journal of surgical pathology.

[10]  E. Jaffe,et al.  EBV Positive Mucocutaneous Ulcer—A Study of 26 Cases Associated With Various Sources of Immunosuppression , 2010, The American journal of surgical pathology.

[11]  M. I. Nassar,et al.  Acute Cytomegalovirus Infection Is a Risk Factor in Refractory and Complicated Inflammatory Bowel Disease , 2009, Digestive Diseases and Sciences.

[12]  Robert E. Brown,et al.  Field effect in cancer-an update. , 2009, Annals of clinical and laboratory science.

[13]  M. Gulley,et al.  Laboratory assays for Epstein-Barr virus-related disease. , 2008, The Journal of molecular diagnostics : JMD.

[14]  J. Lünemann,et al.  Epstein-Barr virus and multiple sclerosis , 2007 .

[15]  R. Longnecker,et al.  Epstein-Barr virus latent membrane protein 2A and autoimmunity. , 2007, Trends in immunology.

[16]  S. Yamanaka,et al.  A case of lymphoepithelioma-like carcinoma of the colon with ulcerative colitis , 2007, Journal of Gastroenterology.

[17]  J. Harley,et al.  The curiously suspicious: a role for Epstein-Barr virus in lupus , 2006, Lupus.

[18]  Christopher F. Martin,et al.  Gastric cancer and the high combination prevalence of host cytokine genotypes and Helicobacter pylori in Honduras. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[19]  T. Fujioka,et al.  Helicobacter pylori-associated oxidant monochloramine induces reactivation of Epstein-Barr virus (EBV) in gastric epithelial cells latently infected with EBV. , 2006, Journal of medical microbiology.

[20]  M. Gulley,et al.  Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. , 2004, The Journal of molecular diagnostics : JMD.

[21]  G. Niedobitek,et al.  Epstein–barr virus (EBV) infection and expression of the interleukin‐12 family member EBV‐induced gene 3 (EBI3) in chronic inflammatory bowel disease , 2004, Journal of medical virology.

[22]  C. Meijer,et al.  Epstein-Barr virus in gastric carcinomas and gastric stump carcinomas: a late event in gastric carcinogenesis , 2004, Journal of Clinical Pathology.

[23]  M. Gulley,et al.  Inter- and Intra-Observer Reliability of Epstein – Barr Virus Detection in Hodgkin Lymphoma using Histochemical Procedures , 2004, Leukemia & lymphoma.

[24]  M. Piazuelo,et al.  The future of gastric cancer prevention , 2004, Gastric Cancer.

[25]  C. V. D. van de Velde,et al.  EBV-positive gastric adenocarcinomas: a distinct clinicopathologic entity with a low frequency of lymph node involvement. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  M. Pender.  Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases. , 2003, Trends in immunology.

[27]  W. Keitel,et al.  Epstein-Barr virus DNA loads in adult human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[28]  N. Shepherd,et al.  Epstein–Barr virus infection in colorectal neoplasms associated with inflammatory bowel disease: detection of the virus in lymphomas but not in adenocarcinomas , 2003, The Journal of pathology.

[29]  M. Miyazaki,et al.  Detection of Epstein-Barr virus in gastric carcinoma cells and surrounding lymphocytes , 2003, Gastric Cancer.

[30]  S. Kenney,et al.  Virally targeted therapies for EBV-associated malignancies , 2003, Oncogene.

[31]  Sang Sook Lee,et al.  Gastric Carcinoma With Lymphoid Stroma: Incidence of EBV and Helicobacter pylori Infection , 2003, Applied immunohistochemistry & molecular morphology : AIMM.

[32]  Yanlong Zhang,et al.  Severe gastritis secondary to Epstein-Barr viral infection. Unusual presentation of infectious mononucleosis and associated diffuse lymphoid hyperplasia in gastric mucosa. , 2003, Archives of pathology & laboratory medicine.

[33]  W. Kaufmann,et al.  The Epstein-Barr Virus Immediate-Early Protein BZLF1 Induces Expression of E2F-1 and Other Proteins Involved in Cell Cycle Progression in Primary Keratinocytes and Gastric Carcinoma Cells , 2002, Journal of Virology.

[34]  A. Simmons.  Herpesvirus and multiple sclerosis. , 2001, Herpes : the journal of the IHMF.

[35]  S. Shousha,et al.  Detection of Epstein-Barr virus in gastrectomy specimens. , 2001, Oncology reports.

[36]  H. Herbst,et al.  Low prevalence of latently Epstein‐Barr virus‐infected cells in chronic gastritis , 2001, Microscopy research and technique.

[37]  Woojun Kim,et al.  Epstein–Barr virus in gastric carcinomas with lymphoid stroma , 2000, Histopathology.

[38]  H. Sugimura,et al.  Epstein-Barr virus-related gastric pseudolymphoma in infectious mononucleosis. , 2000, Gastrointestinal endoscopy.

[39]  H. Herbst,et al.  Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease. , 2000, The American journal of pathology.

[40]  R. Freeman,et al.  Epstein-Barr Virus–Infected Resting Memory B Cells, Not Proliferating Lymphoblasts, Accumulate in the Peripheral Blood of Immunosuppressed Patients , 1999, The Journal of experimental medicine.

[41]  K. Okita,et al.  Epstein-Barr virus infection of the colon with inflammatory bowel disease. , 1999 .

[42]  P. Jipp,et al.  Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease). , 1998, Hepato-gastroenterology.

[43]  K. Okita,et al.  Epstein–Barr virus infection in non‐carcinomatous gastric epithelium , 1997, The Journal of pathology.

[44]  M. Tokunaga,et al.  Epstein‐Barr virus‐positive multiple early gastric cancers and dysplastic lesions: A case report , 1997, Pathology international.

[45]  C. Land,et al.  Morphological characteristics of Epstein‐Barr virus‐related early gastric carcinoma: A case‐control study , 1997, Pathology international.

[46]  D. Shibata,et al.  Elevated antibody titers to Epstein‐Barr virus prior to the diagnosis of Epstein‐Barr‐virus‐associated gastric adenocarcinoma , 1995, International journal of cancer.

[47]  G. Rhodes,et al.  Epstein-Barr virus-induced autoimmune responses. II. Immunoglobulin G autoantibodies to mimicking and nonmimicking epitopes. Presence in autoimmune disease. , 1995, The Journal of clinical investigation.

[48]  S. Leung,et al.  In Situ Detection of Epstein‐Barr Virus in Gastric and Colorectal Adenocarcinomas , 1994, The American journal of surgical pathology.

[49]  T. Osato,et al.  Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[50]  M. Tsuneyoshi,et al.  Epstein‐Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis , 1994 .

[51]  R. Pounder,et al.  Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction , 1992, Journal of medical virology.

[52]  M. Baumann,et al.  Interleukin-5 is an autocrine growth factor for Epstein-Barr virus-transformed B lymphocytes. , 1992, Blood.

[53]  G. Tosato,et al.  Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells , 1990, Journal of virology.

[54]  M. Tuluc,et al.  Ulcerative Gastritis Secondary to Epstein–Barr Viral Infection , 2009, Digestive Diseases and Sciences.

[55]  S. Kenney.  Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors. , 2006, Transactions of the American Clinical and Climatological Association.

[56]  C. Nilsson,et al.  Persistent infection with Helicobacter pylori and the development of gastric cancer. , 2003, Advances in cancer research.

[57]  K. Okita,et al.  Evaluation of Epstein-Barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay , 2003, International journal of gastrointestinal cancer.

[58]  M. Fukayama,et al.  Pathology and molecular pathology of Epstein-Barr virus-associated gastric carcinoma. , 2001, Current topics in microbiology and immunology.

[59]  R Mera,et al.  Loss of p16/CDKN2A tumor suppressor protein in gastric adenocarcinoma is associated with Epstein-Barr virus and anatomic location in the body of the stomach. , 2000, Human pathology.

[60]  T. Yokoi,et al.  Detection of Epstein-Barr virus DNA in gastric carcinoma with lymphoid stroma. , 1997, Viral immunology.

[61]  M. Gulley,et al.  Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. , 1996, Human pathology.

[62]  M. Tsuneyoshi,et al.  Epstein-Barr virus in gastric carcinoma with lymphoid stroma. Special reference to its detection by the polymerase chain reaction and in situ hybridization in 99 tumors, including a morphologic analysis. , 1994, Cancer.